Ann-Marie Roche

Director, Corporate Markets Marketing, Elsevier

Connect with Ann-Marie Roche on LinkedIn
Website: https://www.elsevier.com/

About the author: An experienced and passionate global marketing leader in creating useful, usable and enjoyable customer experiences. I started my career as a researcher and after joining Elsevier, I have had the opportunity to get closer to the fascinating world of Life Sciences, which I now use to identify and further explore key issues such as data as a service, AI, data extraction and personalized medicine. My goal is to engage with my audience and support knowledge sharing and discussion.

Posts by Ann-Marie Roche

Increasing trial participation for new cancer treatments

Posted on September 12th, 2022 in Pharma R&D

Thanks to new and innovative treatments, cancer survival rates continue to improve dramatically – and this will likely only accelerate in the future. Each news cycle seems to carry a new flurry of good news – whether it’s ‘New cancer treatment offers hope to patients out of options’ or ‘How AI in precision medicine is helping find new treatments for brain tumors in children’.

Ontologies – what do they have to do with pharma research?

Posted on August 24th, 2022 in AI & Data

You would be forgiven for thinking that the topic of ontology is more the domain of philosophers or linguists – and not necessarily the concern of someone working in the life sciences. After all, the first definition you get if you Google the word ontology is “the branch of metaphysics dealing with the nature of being”. But dive deeper into the term, and you’ll discover that it’s about classifications of things and their relationships to each other – and that can most certainly be of interest to scientists.

Fighting the stigmatization of monkeypox patients

Posted on August 11th, 2022 in Pharma R&D

When disease outbreaks occur, health experts are not only faced with the challenge of getting good information out to people – they also must battle misinformation. Rumors fly, people share bits and pieces of articles that they only skimmed, and social media posts full of bad science go viral. Sometimes, when the outbreak begins in a certain locality or hits a particular demographic really hard, they must also contend with the problem of stigmatization – which is now happening with the monkeypox outbreak.

Preprints offer early insights into research

Posted on August 9th, 2022 in Pharma R&D

To stay competitive in R&D, it is critical to keep abreast of all the latest findings and innovations. Preprints are offering a new way to remain ahead of the curve, allowing a look into new research prior to the peer-review process.